Mitigating the rare disease RWD deficit

The politics of vaccine replication and access

The animal testing argument

Cell and gene therapy: a victim of its own success

Artificially intelligent drug discovery

Ripples of change in R&D

Going the extra mile for women's health

Decentralised clinical trials: going green

Keeping the spark alive in vaccine development

Time to tackle AMR

Overcoming decentralised clinical trial obstacles

Resilience After Rejection

The Rare Disease Disparity

A Heyday for mRNA

A Fairer Framework for Drug Approvals

A Conversation on Clinical Trial Transformation

Streamlining R&D with 3D

Reaching the Virtual Summit

Drug Launch: It’s a Marathon, not a Sprint

Building a R&D strategy for the Modern Age